FHIR IG analytics| Package | fhir.gdx |
| Resource Type | Observation |
| Id | Observation-HereditaryCancerTestingOverInterNegative.json |
| FHIR Version | R4 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: Observation HereditaryCancerTestingOverInterNegative
Profile: Overall Interpretation
status: Final
category: Laboratory
code: Discrete variation analysis overall interpretation
value: Negative
component
code: Conclusion Text
value: Organization HRD Status: NEGATIVE
component
code: Genetic Result: Negative - No Clinically Significant Mutation Identified
value: Note: "CLINICALLY SIGNIFICANT", as defined in this report, is a genetic change that is associated with the potential to alter medical intervention.
component
code: Breast Cancer Risk Assessment Tool (assessment scale)
value: Breast Cancer RiskScore®: Remaining Lifetime Risk 10.9%
component
code: Clinical History Analysis: No additional management guidelines identified based on the clinical history provded
value: Other clinical factors may influence the individualized management. This analysis may be incomplete if details about cancer diagnoses, ages, family relationships or other factors were omitted or ambiguous. If this patient also has a clinically significant mutation, the recommendations based on the clinical history analysis should be considered in light of the possibility that this mutation explains all or some of the cancer history in the family.
FHIR
FHIRsmith{
"resourceType": "Observation",
"id": "HereditaryCancerTestingOverInterNegative",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/overall-interpretation"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"status": "final",
"category": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/observation-category",
"code": "laboratory"
}
]
}
],
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "51968-6",
"display": "Discrete variation analysis overall interpretation"
}
]
},
"subject": {
"reference": "Patient/PatientFemale"
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://loinc.org",
"code": "LA6577-6",
"display": "Negative"
}
]
},
"specimen": {
"reference": "Specimen/SpecimenBloodFemale"
},
"component": [
{
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code": "conclusion-string"
}
]
},
"valueString": "Organization HRD Status: NEGATIVE"
},
{
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code": "not-clinically-significant",
"display": "Genetic Result: Negative - No Clinically Significant Mutation Identified"
}
]
},
"valueString": "Note: \"CLINICALLY SIGNIFICANT\", as defined in this report, is a genetic change that is associated with the potential to alter medical intervention."
},
{
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "717130009",
"display": "Breast Cancer Risk Assessment Tool (assessment scale)"
}
]
},
"valueString": "Breast Cancer RiskScore®: Remaining Lifetime Risk 10.9%"
},
{
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code": "no-management-guideline",
"display": "Clinical History Analysis: No additional management guidelines identified based on the clinical history provded"
}
]
},
"valueString": "Other clinical factors may influence the individualized management. This analysis may be incomplete if details about cancer diagnoses, ages, family relationships or other factors were omitted or ambiguous. If this patient also has a clinically significant mutation, the recommendations based on the clinical history analysis should be considered in light of the possibility that this mutation explains all or some of the cancer history in the family."
}
]
}